Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol

Fig. 3

An example of clinical report for body composition profiling (AMRA® Profiler 4 MAsS Scan), including whole-body water-fat separated imaging examples (bottom left), the muscle assessment score (MAsS; blue region of the report) which are the biomarkers used in the primary aim to assess sarcopenia, as well as measurements of abdominal adiposity (bottom right)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us